TGR5 modulators and method of use thereof

Details for Australian Patent Application No. 2009316566 (hide)

Owner Intercept Pharmaceuticals, Inc.

Inventors Pellicciari, Roberto

Agent Cullens

Pub. Number AU-A-2009316566

PCT Pub. Number WO2010/059853

Priority 08169462.2 19.11.08 EP

Filing date 19 November 2009

Wipo publication date 27 May 2010

International Classifications

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07J 31/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing sulfur

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059853 Priority application(s): WO2010/059853

14 July 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 May 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316573-Console assembly for a dishwashing appliance, and associated apparatus

2009316562-Multi-layered support system and method thereof